Skip to content

Gummies supplementation for weight management

A randomized, parallel arm controlled clinical trial to assess safety and efficacy of weight management Gummies supplementation. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032126
Enrollment
90
Registered
2021-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Weight Management Gummies: 1 gummy twice a day for 90 days Control Intervention1: Nil: Nil

Sponsors

Aesthetic Nutrition Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Obese patients (male/female and aged between 20-45 yrs.) BMI between 30 - 37 kg/m2 Subjects with or without comorbidities, if comorbidity exists should be on stable prescription and with the following criteria- Hypertension (140/90 mmHg on prescription), Type 2 DM (HbA1C Willing to provide consent Willing for follow up

Exclusion criteria

Exclusion criteria: Subjects with any acute illness requiring immediate medical care. Subjects with Type I DM/Complicated cardiovascular diseases / HbA1C >= 7.5. / History of TIA, Cerebrovascular accident, stroke or any revascularization. Known subjects of hepatic failure/inflammation. Pregnant, breast feeding or planning to become pregnant during the study. Any other condition which proves subject unfit for the study participation

Design outcomes

Primary

MeasureTime frame
Changes in Body Weight Changes in BMI Changes in Quality of life of subjects by IWQOL-Lite score (The Impact of Weight on Quality of Life Questionnaire) in social and emotional aspect Timepoint: Baseline,day 30,day 60,day 90

Secondary

MeasureTime frame
1. Changes in digestive behavior (Bloating, Heartburn, Flatulence, Constipation, Post Prandial Fullness etc.) in subjects 2. Changes in insulin resistance calculated as HOMA-IR score 3. Changes in anthropometric parameters such as Waste/Hip Ratio, Mid upper arm Circumference, Body Fat %, Visceral Fat level % etc. 4. Changes in general complaints like profuse sweating, irregular thirst, dyspnea and uncontrolled hunger on 0-10 VAS score. Timepoint: Baseline, day 30, day 60, day 90

Countries

India

Contacts

Public ContactMr Kapil Mittal

Mprex Healthcare Pvt. Ltd.

gayatri.mbgindia@gmail.com8554912644

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026